Blwyddyn bontio yw hon, wrth inni dreialu mesurau newydd a fydd yn arwain at well canlyniadau i gleifion. Byddwn yn parhau i gadw’r targedau presennol, gan ganolbwyntio ar wella perfformiad ar sail y rhain, a datblygu dulliau newydd ac ystyrlon o fesur canlyniadau ar sail glinigol.
This is a transitional year, as we trial new measures, which will result in better outcomes for all patients. We will continue to retain existing targets and our focus will be to improve performance against these while developing new clinically-led and meaningful outcome measures.